1921
Volume 94, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

We communicate a case of a middle-aged Brazilian patient with an unusual presentation of fourth ventricular neurocysticercosis: occurrence of two intraventricular cysts at different locations in the brain within 2 years and cognitive decline as the only neurological symptom. Neurocysticercosis was confirmed by magnetic resonance imaging, serology, histology, and genetic analysis. Neurocysticercosis should be considered as a differential diagnosis in cases with atypical neurologic or psychiatric symptoms, atypical neuroimaging and travel history. Especially, fourth ventricular cysts carry the risk of obstructive hydrocephalus and brainstem compression and therefore should be extirpated completely. If complete removal of the cystic structures cannot be proven in cases with surgically treated neurocysticercosis, anthelminthic therapy and thorough follow-up examinations should be conducted.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0099
2016-01-06
2017-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/94/1/172.html?itemId=/content/journals/10.4269/ajtmh.15-0099&mimeType=html&fmt=ahah

References

  1. Levine MZ, Calderon JC, Wilkins PP, Lane WS, Asara JM, Hancock K, Gonzalez AE, Garcia HH, Gilman RH, Tsang VC, , 2004. Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection. J Parasitol 90: 631638.[Crossref]
  2. Winkler AS, Blocher J, Auer H, Gotwald T, Matuja W, Schmutzhard E, , 2009. Epilepsy and neurocysticercosis in rural Tanzania—an imaging study. Epilepsia 50: 987993.[Crossref]
  3. Winkler AS, , 2012. Neurocysticercosis in sub-Saharan Africa: a review of prevalence, clinical characteristics, diagnosis, and management. Pathog Glob Health 106: 261274.[Crossref]
  4. Nash TE, Garcia HH, , 2011. Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol 7: 584594.[Crossref]
  5. Takayanagui OM, Odashima NS, , 2006. Clinical aspects of neurocysticercosis. Parasitol Int 55 (Suppl): S111S115.[Crossref]
  6. Del Brutto OH, , 2012. Neurocysticercosis in western Europe: a re-emerging disease? Acta Neurol Belg 112: 335343.[Crossref]
  7. Fleury A, Escobar A, Fragoso G, Sciutto E, Larralde C, , 2010. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors. Trans R Soc Trop Med Hyg 104: 243250.[Crossref]
  8. Takayanagui OM, Odashima NS, Bonato PS, Lima JE, Lanchote VL, , 2011. Medical management of neurocysticercosis. Expert Opin Pharmacother 12: 28452856.[Crossref]
  9. Winkler AS, Richter H, , 2015. Landscape Analysis: Management of Neurocysticercosis with Emphasis on Low- and Middle-Income Countries. Geneva, Switzerland: World Health Organization. Available at: http://apps.who.int/iris/bitstream/10665/152896/1/WHO_HTM_NTD_NZD_2015.05_eng.pdf.
  10. Sinha S, Sharma BS, , 2012. Intraventricular neurocysticercosis: a review of current status and management issues. Br J Neurosurg 26: 305309.[Crossref]
  11. Bergsneider M, Holly LT, Lee JH, King WA, Frazee JG, , 2000. Endoscopic management of cysticercal cysts within the lateral and third ventricles. J Neurosurg 92: 1423.[Crossref]
  12. Amelot A, Faillot T, , 2014. Hydrocephalus and neurocysticercosis: cases illustrative of three distinct mechanisms. J Clin Neurol 10: 363366.[Crossref]
  13. Cuetter AC, Andrews RJ, , 2002. Intraventricular neurocysticercosis: 18 consecutive patients and review of the literature. Neurosurg Focus 12: e5.[Crossref]
  14. Khade P, Lemos RS, Toussaint LG, , 2013. What is the utility of postoperative antihelminthic therapy after resection for intraventricular neurocysticercosis? World Neurosurg 79: 558567.[Crossref]
  15. Tsang VC, Brand JA, Boyer AE, , 1989. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 159: 5059.[Crossref]
  16. Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, Stoner JA, Rainwater E, Dickey M, , 2011. Clinical manifestations associated with neurocysticercosis: a systematic review. PLoS Negl Trop Dis 5: e1152.[Crossref]
  17. Ramirez-Bermudez J, Higuera J, Sosa AL, Lopez-Meza E, Lopez-Gomez M, Corona T, , 2005. Is dementia reversible in patients with neurocysticercosis? J Neurol Neurosurg Psychiatry 76: 11641166.[Crossref]
  18. Rodrigues CL, de Andrade DC, Livramento JA, Machado LR, Abraham R, Massaroppe L, Lucato LT, Caramelli P, , 2012. Spectrum of cognitive impairment in neurocysticercosis: differences according to disease phase. Neurology 78: 861866.[Crossref]
  19. Ciampi de Andrade D, Rodrigues CL, Abraham R, Castro LH, Livramento JA, Machado LR, Leite CC, Caramelli P, , 2010. Cognitive impairment and dementia in neurocysticercosis: a cross-sectional controlled study. Neurology 74: 12881295.[Crossref]
  20. Forlenza OV, Filho AH, Nobrega JP, dos Ramos Machado L, de Barros NG, de Camargo CH, da Silva MF, , 1997. Psychiatric manifestations of neurocysticercosis: a study of 38 patients from a neurology clinic in Brazil. J Neurol Neurosurg Psychiatry 62: 612616.[Crossref]
  21. Kotha VK, , 2013. Migration of intraventricular neurocysticercus after ventriculostomy. Asian J Neurosurg 8: 5456.[Crossref]
  22. Schantz P, Singh G, Prabhakar S, , 2002. Taenia solium cysticercosis: an overview of global distribution and transmission. , eds. Taenia solium Cysticercosis: From Basic to Clinical Science. Chandigarh, India: CABI Pub., 6373.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0099
Loading
/content/journals/10.4269/ajtmh.15-0099
Loading

Data & Media loading...

  • Received : 03 Feb 2015
  • Accepted : 09 Oct 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error